In breast cancer cells, receptor tyrosine kinases (RTKs), such as epidermal growth factor receptor, activate Arf6, by recruiting the guanine nucleotide exchanger GEP100 (also called BRAG2)11. This evidence concerns the gene ARF6 and breast carcinoma.